Please assess the completion status of the following clinical trial:

Trial Title: Study of Denufosol Inhalation Solution in Patients With Mild Cystic Fibrosis Lung Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Have confirmed diagnosis of cystic fibrosis~* Have FEV1 of greater than or equal to 75% of predicted normal for age, gender, and height~* Be able to reproducibly perform spirometry maneuvers~* Be clinically stable for at least 4 weeks prior to screening~Exclusion Criteria:~* Have abnormal renal or liver function~* Have chest x-ray at screening suggesting clinically significant active pulmonary disease~* Be colonized with Burkholderia cepacia~* Have had a lung transplant

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: PLACEBO_COMPARATOR): Placebo
- 2 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).